Peking University Pharmaceuticals announced that Dongxinan Synthetic Pharmaceutical Group Co., Ltd., which holds more than 5% of its shares, has been judicially enforced due to a financing and securities transaction dispute. From August 5 to September 1, 2026, Zhongtai Securities sold a total of 5.9597 million shares of the company's shares held by Southwest Synthetic through centralized bidding, accounting for 1% of the company's total share capital, and the average execution price was 5.49 yuan/share. Judicial enforcement of this centralized bidding method has been completed, and part of the bulk transaction method has not yet been completed. After execution, Southwest Synthetic held 121 million shares of the company, accounting for 20.22% of the total share capital.

Peking University Pharmaceuticals announced that Dongxinan Synthetic Pharmaceutical Group Co., Ltd., which holds more than 5% of its shares, has been judicially enforced due to a financing and securities transaction dispute. From August 5 to September 1, 2026, Zhongtai Securities sold a total of 5.9597 million shares of the company's shares held by Southwest Synthetic through centralized bidding, accounting for 1% of the company's total share capital, and the average execution price was 5.49 yuan/share. Judicial enforcement of this centralized bidding method has been completed, and part of the bulk transaction method has not yet been completed. After execution, Southwest Synthetic held 121 million shares of the company, accounting for 20.22% of the total share capital.